| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/03/1993 | CN1069408A Pharmaceuctical spheroid formulation |
| 03/03/1993 | CN1019973C Piperidine derivative and pharmaceutical composition containing the same |
| 03/02/1993 | US5191067 For treatment of fibroblast growth factor mediated pathophysiological conditions |
| 03/02/1993 | US5190971 Substituted dibenz-oxa-thiocinones, -12-oxides and -12,12-dioxides, a process for their preparation and their use in medicaments |
| 03/02/1993 | US5190948 Use of uridine in the pharmacological treatment of the peripheral complications of diabetes |
| 03/02/1993 | US5190941 Use of naphthoxazines for the treatment of conditions associated with cerebral ischaemia |
| 03/02/1993 | US5190939 Antihypoxic |
| 03/02/1993 | US5190938 Elastase inhibitors, treatment of cystic fibrosis, atherosclerosis, rheumatic diseases |
| 03/02/1993 | US5190935 Vitamin d analogues |
| 03/02/1993 | US5190589 Compounds and process preparing a substituted or an unsubstituted 4(5)-(ω-aminoalkyl)imidazole |
| 03/02/1993 | CA1314044C Imidazopyridine derivatives |
| 03/01/1993 | CA2077098A1 Benzopyran derivatives |
| 03/01/1993 | CA2076995A1 Cloning and characterization of a cardiac adenylyl cyclase |
| 03/01/1993 | CA2076929A1 Substituted mandelic acid derivatives, processes for their preparation and their use in medicaments |
| 03/01/1993 | CA2073833A1 Substituted 1-phenyl-1-benzoylamino-5-aminopentanes, their preparation and use |
| 02/24/1993 | EP0528762A1 N-acyl-N-heterocyclyl- or naphthyl-alkyl amino acids as angiotensin II antagonists |
| 02/24/1993 | EP0528633A1 Pyrimidinyl acetamides as elastase inhibitors |
| 02/24/1993 | EP0528515A2 HMG-CoA reductase inhibitors in the prevention of restenosis following coronary angioplasty |
| 02/24/1993 | EP0528500A2 A method for reduction of central nervous system (CNS) edema resulting from head and spinal cord trauma |
| 02/24/1993 | EP0528369A2 Cyclic imino derivatives, pharmaceutical compositions containing them and process for their preparation |
| 02/24/1993 | EP0528312A2 Cyclic peptides and use thereof |
| 02/24/1993 | EP0528172A1 (2-Alkyl-3-pyridyl)methylpiperazine derivatives as PAF antagonists |
| 02/24/1993 | EP0528146A1 N-phenylthiourea derivatives and pharmaceutical use thereof |
| 02/24/1993 | EP0527851A1 1h-substituted-1,2,4-triazole compounds for treatment of cardiovascular disorders |
| 02/24/1993 | EP0527801A1 Thiophene sulfonamides useful as carbonic anydrase inhibitors |
| 02/24/1993 | CN1069191A Pharmaceutical combination formulation |
| 02/24/1993 | CA2076553A1 1,7-fused 2-(piperazinoalkyl) indole derivatives, processes and intermediates for their preparation, and pharmaceutical compositions containing them |
| 02/23/1993 | US5189211 Thromboxane A2 antagonists |
| 02/23/1993 | US5189179 Serotonin 5ht1a agonists |
| 02/23/1993 | US5189178 Preventing protein destruction |
| 02/23/1993 | US5189149 High concentration, solvent-free |
| 02/23/1993 | US5189148 Fibroblast growth factor; mixture with water insoluble hydroxypropyl cellulose |
| 02/23/1993 | US5189047 Useful in the treament of respiratory track disorder, hypertension and bronchodilator activity or utility as potassium channel activator |
| 02/23/1993 | US5189043 Isoquinolone derivatives, their production and use |
| 02/23/1993 | US5189041 Gastrointestinal and nervous system disorders, cardiovascular disorders, analgesics |
| 02/23/1993 | US5189036 Imidazolylbenzoyl substituted heterocycles |
| 02/23/1993 | US5189034 Vasodilating, antianginal agents |
| 02/23/1993 | US5189018 Method for reduction of central nervous system (cns) edema resulting from head and spinal cord trauma |
| 02/23/1993 | CA2076573A1 Benzodioxane derivatives |
| 02/23/1993 | CA2076558A1 Pharmaceutical compositions containing bradykinin antagonists for local use on the nose and eyes |
| 02/23/1993 | CA1313872C Acetamide derivatives of dihydro-2,3-phenyl-3 -benzofuran-2-one, processes for their preparation and pharmaceutical compositions containing them |
| 02/23/1993 | CA1313870C Derivatives of morpholine and their preparation process |
| 02/21/1993 | CA2076443A1 1-(alcoxybenzyl)piperazins amidic compounds, process for their preparation and pharmaceutical compositions containing same |
| 02/20/1993 | CA2076321A1 Method for reduction of central nervous system (cns) edema resulting from head and spinal cord trauma |
| 02/20/1993 | CA2076311A1 Cyclic imino derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 02/18/1993 | WO1993003059A1 Cyclic hexapeptides as tachyquinin antagonists, their preparation and pharmaceutical compositions thereof |
| 02/18/1993 | WO1993003037A1 Organic nitrates, methods for preparing same and use thereof for treating cardiovascular diseases |
| 02/18/1993 | WO1993003018A1 Compounds having angiotensine ii antagonistic activity |
| 02/18/1993 | WO1993003016A1 Benzimidazolone derivatives as 5-ht1a and 5-ht2 antagonists |
| 02/18/1993 | WO1993003015A1 Heteroalkoxy benzazepines |
| 02/18/1993 | WO1993003014A1 Dihydropyridine derivatives, and process for their preparation |
| 02/18/1993 | WO1993002701A1 Buffered formulation of peg-sod |
| 02/18/1993 | WO1993002693A2 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
| 02/18/1993 | WO1993002688A1 Plant-based medicament for enhancing and controlling the tone of smooth-muscle organs |
| 02/18/1993 | WO1993002677A1 5-ht4 receptor antagonists |
| 02/18/1993 | WO1993000095A3 Bicyclic fibrinogen antagonists |
| 02/18/1993 | WO1992020651A3 N-(heteroaryl)-imidazolyl-alkenoic acids |
| 02/18/1993 | WO1992019613A3 1,2-dithiole-3-thione derivative-based therapeutical compositions |
| 02/18/1993 | CA2114621A1 Compounds having angiotensine ii antagonistic activity |
| 02/18/1993 | CA2114240A1 Buffered formulation of peg-sod |
| 02/18/1993 | CA2113922A1 Organic nitrates, processes for their preparation and their use in the treatment of cardiovascular diseases |
| 02/17/1993 | EP0527646A1 New compounds named the adenophostins, their preparation and their therapeutic use |
| 02/17/1993 | EP0527638A1 Compositions comprising diltiazem in sustained release form and hydrochlorothiazide in immediate release form |
| 02/17/1993 | EP0527637A1 Spheroids containing dittiazem and a spheronizing agent |
| 02/17/1993 | EP0527624A2 Use of a selective inhibitor of neutral endopeptidase and an angiotensin converting enzyme inhibitor in the preparation of a pharmaceutical for treating congestive heart failure |
| 02/17/1993 | EP0527534A1 Quinoline and azaquinoline angiotensin II antagonists |
| 02/17/1993 | EP0527458A1 New 3,5-di-tert.-butyl-4-hydroxyphenyl derivatives, process for their preparation and pharmaceutical compounds |
| 02/17/1993 | EP0527181A1 Heterocyclicethenediyl compounds which inhibit egf receptor tyrosine kinase |
| 02/17/1993 | CN1069025A Aryl, amide, imide, and carbamate pyridine antagonists of platelet activating factor |
| 02/17/1993 | CN1069024A Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for preparation thereof |
| 02/17/1993 | CN1069023A 4-(2-hydroxy-2-phenylethylamino) ethoxy) phenylacetic acid derivatives used in therapy obesity and related state |
| 02/17/1993 | CN1069022A 4-(2-(2-hydroxy-2-phenylethylamino) ethoxy) phenylacetic acid derivatives used in therapy obesity and related state |
| 02/16/1993 | US5187195 Anthraquinone derivatives and preparation thereof |
| 02/16/1993 | US5187179 Angiotensin II antagonists incorporating a substituted imidazo [1,2-b][1,2,4]triazole |
| 02/16/1993 | US5187168 Substituted quinazolines as angiotensin II antagonists |
| 02/16/1993 | US5187159 Angiotensin II antagonists incorporating a substituted 1,3-benzodioxole or 1,3-benzodithiole |
| 02/16/1993 | CA2076057A1 N-acyl-n-heterocyclylalkylamino acids, processes, compositions and use |
| 02/14/1993 | CA2075652A1 Quinoline and azaquinoline angiotensin ii antagonists incorporating a substituted benzyl element |
| 02/13/1993 | CA2075671A1 Treatment of congestive heart failure |
| 02/13/1993 | CA2075356A1 Pharmaceutical spheroid formulation |
| 02/13/1993 | CA2075355A1 Pharmaceutical combination formulation |
| 02/10/1993 | EP0527081A1 Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use |
| 02/10/1993 | EP0527079A1 N-(isoquinolein-5-yl)-sulfonyl azacycloalkanes, their process of preparation and pharmaceutical compositions containing them |
| 02/10/1993 | EP0526905A2 Multimers of the soluble forms of TNF receptors, their preparation and pharmaceutical compositions containing them |
| 02/10/1993 | EP0526866A1 The use of adenosine compounds for the preparation in the treatment of ischaemia |
| 02/10/1993 | EP0526708A1 Sulfonamide, preparation and use thereof as medicine and intermediate |
| 02/10/1993 | EP0526540A1 Use of 5-ht 4? receptor antagonists in the treatment of arrythmias and stroke |
| 02/10/1993 | EP0526529A1 An improved process for the preparation of substituted indolone derivatives. |
| 02/10/1993 | EP0526495A1 1,5-benzothiazepinone derivatives, their preparations and pharmaceutical use |
| 02/10/1993 | EP0526452A1 Hybrid immunoglobulins |
| 02/10/1993 | CN1068821A 苯并二氢吡喃衍生物 Chroman derivatives |
| 02/10/1993 | CN1068737A Antihypertensive composition |
| 02/09/1993 | US5185442 New diazepines substituted in the 6-position, processes for their preparation and their use as pharmaceutical compositions |
| 02/09/1993 | US5185361 Pharmaceutical compounds |
| 02/09/1993 | US5185352 Alkoxy-4(1h)-pyridone derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| 02/09/1993 | US5185351 Hypotensive agents; for treatment of congestive heart failure, renal failure and glaucoma |
| 02/09/1993 | US5185324 Enzyme-inhibiting amino acid derivatives, a process for the preparation thereof, agents containing these, and the use thereof |
| 02/09/1993 | CA2075673A1 (2-alkyl-3-pyridyl)methylpiperazine derivatives |
| 02/09/1993 | CA2075459A1 Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as hmg-coa reductase inhibitors |
| 02/09/1993 | CA1313526C 2-dithioalkyl-dihydropyridines, a method for their preparation and pharmaceutical compositions containing them |